Dupilumab Treatment in Two Patients with Cutaneous T-cell Lymphomas
Authors:
- C Ram-WolffCRC Ram-Wolff
- J BouazizJBJ Bouaziz
- E BégonEBE Bégon
- M BattistellaMBM Battistella
- J RivetJRJ Rivet
- M JachietMJM Jachiet
- M BagotMBM Bagot
- A MassonAMA Masson
Open Access
- 30 September 2020
- journal article
- editorial
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 100 (16) , adv00271
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trialsThe Lancet, 2019
- Clinical severity measures and quality‐of‐life burden in patients with mycosis fungoides and Sézary syndrome: comparison of generic and dermatology‐specific instrumentsJournal of the European Academy of Dermatology and Venereology, 2019
- Diagnosis of Mycosis Fungoides Following Administration of Dupilumab for Misdiagnosed Atopic DermatitisActa Dermato-Venereologica, 2019
- TH2 Cytokines from Malignant Cells Suppress TH1 Responses and Enforce a Global TH2 Bias in Leukemic Cutaneous T-cell LymphomaClinical Cancer Research, 2013